Develops programmable mRNA-based therapeutics for precise, targeted, and controlled treatment of unmet medical needs.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Radar Therapeutics is a biotech company developing programmable precision therapeutics. Leveraging innovative mRNA technology and proprietary regulatory control elements, the company aims to revolutionize medicine by enabling targeted, timely, and controlled therapeutic interventions. Radar is committed to advancing the boundaries of genetic medicine to address unmet medical needs and improve patient access.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Radar Therapeutics Management Team
Investors
BEV Capital
Eli Lilly and Company
KdT Ventures
NfX Bio
PearVC
Radar Therapeutics Valuations & Financials
View real-time NPM data on Radar Therapeutics stock including daily Radar Therapeutics stock price estimates, valuation history, and historical share price information. Access Radar Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Radar Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Radar Therapeutics? Get in touch to learn more.
Similar Companies
like Radar Therapeutics
Newleos Therapeutics
Healthcare & Life Sciences
Develops oral medicines that modulate neural targets to treat core symptoms of neuropsychiatric conditions with reduced side effects.
Eximis Surgical
Healthcare & Life Sciences
Enabling surgeons to remove large specimens through small incisions with a contained, efficient system.
Triveni Bio
Healthcare & Life Sciences
Biotechnology company developing antibody-based therapies for immunological disorders using genetics-informed precision medicine approaches.
Delphia Therapeutics
Healthcare & Life Sciences
Pioneers cancer therapies that exploit oncogene overactivation to create targeted, resistance-fighting treatments.
Atia Vision
Healthcare & Life Sciences
Develops a modular, shape-changing intraocular lens that restores full-range vision for cataract patients using natural eye accommodation.
Tubulis
Healthcare & Life Sciences
Develops advanced antibody-drug conjugates using proprietary technology to create targeted cancer therapies with enhanced effectiveness.
Nimble RX
Healthcare & Life Sciences
Enables individuals to manage their health and wellness through innovative technology solutions.
Eden Health
Healthcare & Life Sciences
Delivers seamless, data-driven healthcare by combining primary care, 24/7 telemedicine, and insurance navigation in one platform.
Orionis Biosciences
Healthcare & Life Sciences
Reprogram cellular and protein interactions to enable targeted treatment and enhanced immune response.
FAQ
We have answers
Radar Therapeutics stock does not trade on public stock exchanges. Radar Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Radar Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Radar Therapeutics Stock does not trade on public stock exchanges. In order to sell Radar Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Radar Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Radar Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Radar Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Radar Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Radar Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Radar Therapeutics is a private company and has not had an IPO. There is currently no Radar Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Radar Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
